Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy

This publication has 32 references indexed in Scilit:

• Dexamethasone Alone or in Combination with Ondansetron for the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
  New England Journal of Medicine, 2000
• Effects of anti‐emetic drug (tropisetron) on quality of life during chemotherapy: Use of a diary‐type questionnaire and application of summary measures for assessment in a randomized, multicentre study
  Respirology, 1999
• Effect of postchemotherapy nausea and vomiting on health-related quality of life
  Supportive Care in Cancer, 1997
• Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life
  Clinical Therapeutics, 1996
• On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993
  Annals of Oncology, 1996
• Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients
  European Journal Of Cancer, 1995
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• Quality of life consequences of chemotherapy-induced emesis
  Quality of Life Research, 1992
• Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer
  Oncology, 1992
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983